Name: Armotraz
SKU: 24103
Availability: InStock

📋 Product Overview Table

🌐 Specification	🧾 Details
💊 Active Ingredient	Anastrozole 1mg
🧪 Formulation	Aromatase Inhibitor Tablet
🏭 Manufacturer	Cipla Limited
💊 Dosage Form	Oral Tablet
📦 Packaging	10 Tablets in 1 Strip
🩺 Indication	Estrogen receptor-positive breast cancer in postmenopausal women
🇺🇸 US Brand Equivalent	Arimidex (by AstraZeneca)
⏱️ Delivery Time	6 to 15 days

🧬 Introduction – What is Armotraz (Anastrozole) 1mg?

Armotraz is a prescription medication containing Anastrozole, a powerful non-steroidal aromatase inhibitor, used to manage hormone receptor-positive breast cancer in postmenopausal women. Manufactured by Cipla Limited, a globally recognized Indian pharmaceutical company, Armotraz offers a cost-effective and clinically trusted alternative to the brand-name drug Arimidex.

It works by blocking aromatase, an enzyme that helps produce estrogen. Since some breast cancers rely on estrogen to grow, Armotraz helps slow or stop tumor growth by lowering estrogen levels in the body. It is commonly used as adjuvant therapy after surgery, or as first-line treatment in metastatic cases.

🎥 Video Overview – How Armotraz Works

📺 “Understanding Aromatase Inhibitors: Armotraz (Anastrozole) Explained“

🎬 Video Placeholder – Covers the mechanism, duration of therapy, and expected outcomes.

Always follow your oncologist’s prescription and review side effects regularly.

🔬 Pharmacology & Mechanism of Action

🧪 Parameter	📊 Details
Drug Class	Aromatase Inhibitor (Non-steroidal)
Mechanism	Inhibits conversion of androgens to estrogens
Bioavailability	Approximately 85% (oral)
Metabolism	Liver (CYP450 pathways)
Elimination Half-Life	Around 50 hours
Excretion	Renal and fecal

💡 Dosing Instructions

🗓️ Regimen	💊 Dose
Standard Adult Dose	1mg tablet once daily
With Food?	May be taken with or without food
Duration	Often prescribed for 5 years

Missed a dose? Take it as soon as possible, but skip it if it’s almost time for the next dose.

⚠️ Side Effects & Medical Warnings

💥 Common Effects	❗ Serious Side Effects (Rare)
Hot flashes	Bone thinning/osteoporosis
Joint/muscle pain	Liver dysfunction
Nausea, fatigue	Cardiovascular risks (elderly)

Do NOT use if premenopausal, pregnant, or have severe liver conditions. Monitor bone density during long-term therapy.

🧃 Storage Guidelines

Store in a cool, dry place under 25°C
Keep away from moisture and direct sunlight
Store out of reach of children

🌍 Global Availability & Import Guidelines

🌎 Country	📦 Import Policy	📋 Prescription Required
🇺🇸 USA	Permitted under FDA personal import policy	Yes
🇬🇧 UK	Import allowed via MHRA guidelines	Yes
🇦🇺 Australia	TGA allows personal import with prescription	Yes

🔗 Related Oncology Therapies (Internal Links)

💊 Product Name	🏭 Manufacturer	📖 Description
Letoval 2.5mg	Sun Pharma	Letrozole-based aromatase inhibitor for postmenopausal breast cancer
Tamoxifen 20mg	Kachhela Medex	SERM for ER-positive breast cancer, often used in younger women
Fempro 2.5mg	Cipla Ltd	Oral Letrozole tablet used in early-stage and advanced breast cancers
Exemestane 25mg	Natco Pharma	Steroidal aromatase inhibitor for resistant or progressive cases
Altraz 1mg	Alkem Labs	Anastrozole tablet similar in action to Armotraz

📚 Authoritative Medical References

🩺 Expert Review – Dr. Neha Bansal, MD (Medical Oncology)

“Armotraz by Cipla is a reliable and widely used aromatase inhibitor in India and internationally. It’s a vital part of hormone-based breast cancer therapy for postmenopausal women. Patients on long-term therapy should be monitored for bone health and cardiovascular risks.”

⚠️ Disclaimer

This article is for informational purposes only. Armotraz should be used only under medical supervision. Import and prescription regulations vary by country.